최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of the Korean Society of Integrative Medicine = 대한통합의학회지, v.8 no.4, 2020년, pp.79 - 92
천성민 (순천향대학교 서울병원 재활의학과) , 최윤희 (순천향대학교 서울병원 재활의학과)
Purpose : The purpose of this study was to evaluate the prescription pattern of NSAIDs and GPAs in the arthritis patients over 65 years old to prevent the GI adverse events. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most commonly used agents to treat arthritis, can cause gastrointestinal...
Bombardier C, Laine L, Reicin A, et al(2000). Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med, 343(21), 1520-1528. https://doi.org/10.1056/NEJM200011233432103.
Carvajal A, Martin Arias LH, Vega E, et al(2004). Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study. Eur J Clin Pharmacol, 60(6), 439-444. https://doi.org/10.1007/s00228-004-0782-8.
Chan FKL, Lanas A, Scheiman J, et al(2010). Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet, 376(9736), 173-179. https://doi.org/10.1016/S0140-6736(10)60673-3.
Gabriel SE, Jaakkimainen L, Bombardier C(1991). Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med, 115(1), 787-796. https://doi.org/0.7326/003-4819-115-10-787.
Glasziou P, Haynes B(2005). The paths from research to improved health outcomes. BMJ Evidence-Based Medicine, 10(1), 4-7. https://doi.org/10.1136/ebm.10.1.4-a.
Griffin MR, Piper JM, Daugherty JR, et al(1991). Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med, 114(4), 257-263. https://doi.org/10.7326/003-4819-114-4-257.
Griffin MR, Ray WA, Schaffner W(1988). Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med, 109(5), 359-363. https://doi.org/10.7326/0003-4819-109-5-359.
Han MH, Nam JH, Noh ES, et al(2019). Gastrointestinal risk of non-steroidal anti-inflammatory drugs and gastroprotective agents used in the treatment of osteoarthritis in elderly patients: A nationwide retrospective cohort study. Int J Clin Pharmacol Ther, 57(11), 531-541. https://doi.org/10.5414/CP203377.
Kim HC, Lee MC, Moon YW, et al(2011). The pattern of use of oral NSAIDs with or without co-prescription of gastroprotective agent for arthritic knee by Korean practitioners. Knee Surg Relat Res, 23(4), 203-207.
Kim YI, Kim SM(2019). National health insurance statistical yearbook. Wonju, National Health Insurance Service and Health Insurance Review & Assessment Service.
Korea Centers for Disease Control and Prevention(2017). The seventh Korea National Health and Nutrition Examination Survey (KNHANES VII-2). Korea centers for disease control and prevention.
Lanza FL, Chan FKL, Quigley EMM(2009). Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol, 104(3), 728-738. https://doi.org/10.1038/jg.2009.115.
Larkai EN, Smith JL, Lidsky MD, et al(1987). Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol, 82(11), 1153-1158.
Micklewright R, Lane S, Linley W, et al(2003). Review article: NSAIDs, gastroprotection and cyclo-oxygenaseI-selective inhibitors. Aliment Pharmacol Ther, 17(3), 321-332. https://doi.org/10.1046/j.1365-2036.2003.01454.x.
Richmond J, Hunter D, Irrgang J, et al(2009). Treatment of Osteoarthritis of the Knee (Nonarthroplasty). J Am Acad Orthop Surg, 17(9), 591-600. https://doi.org/10.5435/00124635-200909000-00006.
Rostom A, Dube C, Wells GA, et al(2002). Prevention of NSAID-induced gastroduodenal ulcers. Cochrane database Syst Rev. Printed Online. https://doi.org/0.1002/4651858.CD002296.
Silverstein FE, Faich G, Goldstein JL, et al(1987). Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. JAMA, 284(10), 1247-1255. https://doi.org/10.1001/jama.284.10.1247.
Tenenbaum J(1999). The epidemiology of nonsteroidal anti-inflammatory drugs. Can J Gastroenterol, 13(2), 119-122. https://doi.org/10.1155/1999/361651.
Tsumura H, Tamura I, Tanaka H, et al(2007). Prescription of nonsteroidal anti-inflammatory drugs and co-prescribed drugs for mucosal protection: analysis of the present status based on questionnaires obtained from orthopedists in Japan. Intern Med, 46(13), 927-931. https://doi.org/10.2169/internalmedicine.46.0003.
Valkhoff VE, Van Soest EM, Masclee GMC, et al(2012). Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal -a 617,400-patient study. Aliment Pharmacol Ther, 36(8), 790-799. https://doi.org/10.1111/apt.12028.
Wolfe MM, Lichtenstein DR, Singh G(1999). Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med, 340(24), 1888-1899. https://doi.org/10.1056/NEJM199906173402407.
Zhang W, Moskowitz RW, Nuki G, et al(2008). OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil, 16(2), 137-162. https://doi.org/10.1016/j.joca.2007.12.013.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.